Skip to main content
Top
Published in: Clinical Rheumatology 5/2011

01-05-2011 | Original Article

Osteomalacia revisited

A report on 28 cases

Authors: Laia Gifre, Pilar Peris, Ana Monegal, Maria Jesús Martinez de Osaba, Luisa Alvarez, Núria Guañabens

Published in: Clinical Rheumatology | Issue 5/2011

Login to get access

Abstract

The aim of this study was to analyse the clinical manifestations and the most frequent causes of osteomalacia (OM) in a group of 28 patients diagnosed with this disorder during a 20-year period. OM was diagnosed by bone biopsy and/or by Bingham and Fitzpatrick criteria (two of the following: low calcium, low phosphate, elevated total alkaline phosphatase [total AP] or suggestive radiographs). Of these patients, 13 had vitamin D deficiency OM (VD-OM), 14 hypophosphatemic OM (HypoP-OM) and one had OM-associated hypophosphatasia. Deficient sun exposure and celiac disease were the most frequent etiologies of VD-OM, whereas most HypoP-OM were hereditary forms. The main clinical symptoms were polyarthralgias (89%), frequently associated with fractures (75%). Fifty seven percent had densitometric criteria of osteoporosis. Patients with VD-OM showed significantly higher total AP and PTH serum values, but lower vitamin D, serum calcium, calciuria and bone mass than patients with HypoP-OM. Conversely, HypoP-OM patients had significantly lower serum phosphate and higher phosphaturia than patients with VD-OM. Briefly, high total AP, low serum calcium and low serum phosphate were observed in 85%, 65% and 15%, respectively, of patients with VD-OM, being observed in 64%, 14% and 100%, respectively, of HypoP-OM patients. Nearly 50% of these latter showed increased FGF23 levels. In conclusion, in this study, the frequencies of HypoP-OM and VD-OM were similar. The most frequent laboratory abnormalities were increased total AP and decreased serum phosphate. A urinary calcium loss of less than 50 mg/dl was highly discriminatory for VD-OM and a serum phosphate less than 2.3 mg/dl was also high discriminatory for HypoP-OM. Low densitometric values and fractures were frequent among these patients.
Literature
1.
go back to reference Reginato AJ, Falasca GF, Pappu R, McKnight B, Agha A (1999) Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review. Semin Arthritis Rheum 28:287–304PubMedCrossRef Reginato AJ, Falasca GF, Pappu R, McKnight B, Agha A (1999) Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review. Semin Arthritis Rheum 28:287–304PubMedCrossRef
2.
go back to reference Reginato AJ, Coquia JA (2003) Musculoskeletal manifestations of osteomalacia and rickets. Best Pract Res Clin Rheumatol 17:1063–1080PubMedCrossRef Reginato AJ, Coquia JA (2003) Musculoskeletal manifestations of osteomalacia and rickets. Best Pract Res Clin Rheumatol 17:1063–1080PubMedCrossRef
3.
go back to reference Fukumoto S, Yamashita T (2007) FGF23 is a hormone-regulating phosphate metabolism—unique biological characteristics of FGF23. Bone 40:1190–1195PubMedCrossRef Fukumoto S, Yamashita T (2007) FGF23 is a hormone-regulating phosphate metabolism—unique biological characteristics of FGF23. Bone 40:1190–1195PubMedCrossRef
4.
go back to reference Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663PubMedCrossRef Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663PubMedCrossRef
5.
go back to reference Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 95:519–523PubMedCrossRef Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 95:519–523PubMedCrossRef
6.
go back to reference Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 9:2055–2061CrossRef Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 9:2055–2061CrossRef
7.
go back to reference Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309–310PubMedCrossRef Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309–310PubMedCrossRef
9.
go back to reference Stechschulte SA, Kirsner RS, Federman DG (2009) Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med 122:793–802PubMedCrossRef Stechschulte SA, Kirsner RS, Federman DG (2009) Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med 122:793–802PubMedCrossRef
10.
go back to reference (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization technical report series 843:1–129 (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization technical report series 843:1–129
12.
go back to reference Finch PJ, Ang L, Eastwood JB, Maxwell JD (1992) Clinical and histological spectrum of osteomalacia among Asians in south London. Q J Med 83:439–448PubMed Finch PJ, Ang L, Eastwood JB, Maxwell JD (1992) Clinical and histological spectrum of osteomalacia among Asians in south London. Q J Med 83:439–448PubMed
13.
go back to reference Erkal MZ, Wilde J, Bilgin Y, Akinci A, Demir E, Bödeker RH, Mann M, Bretzel RG, Stracke H, Holick MF (2006) High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 17:1133–1140PubMedCrossRef Erkal MZ, Wilde J, Bilgin Y, Akinci A, Demir E, Bödeker RH, Mann M, Bretzel RG, Stracke H, Holick MF (2006) High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 17:1133–1140PubMedCrossRef
14.
go back to reference Fogelman Y, Rakover Y, Luboshitzky R (1995) High prevalence of vitamin D deficiency among Ethiopian women immigrants to Israel: exacerbation during pregnancy and lactation. Isr J Med Sci 3:221–224 Fogelman Y, Rakover Y, Luboshitzky R (1995) High prevalence of vitamin D deficiency among Ethiopian women immigrants to Israel: exacerbation during pregnancy and lactation. Isr J Med Sci 3:221–224
15.
go back to reference Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD (2000) A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 15:557–563PubMedCrossRef Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD (2000) A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 15:557–563PubMedCrossRef
16.
go back to reference McKenna MJ, Freaney R, Casey OM, Towers RP, Muldowney FP (1983) Osteomalacia and osteoporosis: evaluation of a diagnostic index. J Clin Pathol 36:245–252PubMedCrossRef McKenna MJ, Freaney R, Casey OM, Towers RP, Muldowney FP (1983) Osteomalacia and osteoporosis: evaluation of a diagnostic index. J Clin Pathol 36:245–252PubMedCrossRef
17.
go back to reference Johnson MW, Ellis HJ, Asante MA, Ciclitira PJ (2008) Celiac disease in the elderly. Nat Clin Pract Gastroenterol Hepatol 5:697–706PubMedCrossRef Johnson MW, Ellis HJ, Asante MA, Ciclitira PJ (2008) Celiac disease in the elderly. Nat Clin Pract Gastroenterol Hepatol 5:697–706PubMedCrossRef
18.
go back to reference Vilppula A, Kaukinen K, Luostarinen L, Krekelä I, Patrikainen H, Valve R, Mäki M, Collin P (2009) Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol 9:49PubMedCrossRef Vilppula A, Kaukinen K, Luostarinen L, Krekelä I, Patrikainen H, Valve R, Mäki M, Collin P (2009) Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol 9:49PubMedCrossRef
19.
go back to reference Bikle DD (2007) Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res 22(Suppl 2):V50–V54PubMedCrossRef Bikle DD (2007) Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res 22(Suppl 2):V50–V54PubMedCrossRef
20.
go back to reference McMahon MM, Sarr MG, Clark MM, Gall MM, Knoetgen J III, Service FJ, Laskowski ER, Hurley DL (2006) Clinical management after bariatric surgery: value of a multidisciplinary approach. Mayo Clin Proc 81(10 Suppl):S34–S45PubMed McMahon MM, Sarr MG, Clark MM, Gall MM, Knoetgen J III, Service FJ, Laskowski ER, Hurley DL (2006) Clinical management after bariatric surgery: value of a multidisciplinary approach. Mayo Clin Proc 81(10 Suppl):S34–S45PubMed
21.
go back to reference Malinowski SS (2006) Nutritional and metabolic complications of bariatric surgery. Am J Med Sci 331:219–225PubMedCrossRef Malinowski SS (2006) Nutritional and metabolic complications of bariatric surgery. Am J Med Sci 331:219–225PubMedCrossRef
22.
go back to reference Gasteyger C, Suter M, Gaillard RC, Giusti V (2008) Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr 87:1128–1133PubMed Gasteyger C, Suter M, Gaillard RC, Giusti V (2008) Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr 87:1128–1133PubMed
23.
go back to reference Compher CW, Badellino KO, Boullata JI (2008) Vitamin D and the bariatric surgical patient: a review. Obes Surg 18:220–224PubMedCrossRef Compher CW, Badellino KO, Boullata JI (2008) Vitamin D and the bariatric surgical patient: a review. Obes Surg 18:220–224PubMedCrossRef
24.
go back to reference Flechner SM, Kobashigawa J, Klintmalm G (2008) Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22:1–15PubMedCrossRef Flechner SM, Kobashigawa J, Klintmalm G (2008) Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22:1–15PubMedCrossRef
25.
go back to reference McLin VA, Girardin E, Lecoultre C, Mentha G, Belli DC (2005) Glomerular and tubular function following orthotopic liver transplantation in children. Pediatr Transplant 9:512–519PubMedCrossRef McLin VA, Girardin E, Lecoultre C, Mentha G, Belli DC (2005) Glomerular and tubular function following orthotopic liver transplantation in children. Pediatr Transplant 9:512–519PubMedCrossRef
26.
go back to reference Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235–1239PubMedCrossRef Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235–1239PubMedCrossRef
27.
go back to reference Heijboer AC, Levitus M, Vervloet MG, Lips P, ter Wee PM, Dijstelbloem HM, Blankenstein MA (2009) Determination of fibroblast growth factor 23. Ann Clin Biochem 46:338–340PubMedCrossRef Heijboer AC, Levitus M, Vervloet MG, Lips P, ter Wee PM, Dijstelbloem HM, Blankenstein MA (2009) Determination of fibroblast growth factor 23. Ann Clin Biochem 46:338–340PubMedCrossRef
28.
go back to reference Ito N, Fukumoto S, Takeuchi Y, Yasuda T, Hasegawa Y, Takemoto F, Tajima T, Dobashi K, Yamazaki Y, Yamashita T, Fujita T (2005) Comparison of two assays for fibroblast growth factor (FGF)-23. J Bone Miner Metab 23:435–440PubMedCrossRef Ito N, Fukumoto S, Takeuchi Y, Yasuda T, Hasegawa Y, Takemoto F, Tajima T, Dobashi K, Yamazaki Y, Yamashita T, Fujita T (2005) Comparison of two assays for fibroblast growth factor (FGF)-23. J Bone Miner Metab 23:435–440PubMedCrossRef
29.
go back to reference Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Lichtner P, Schnabel D, Hochberg Z, Strom TM (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78:193–201PubMedCrossRef Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Lichtner P, Schnabel D, Hochberg Z, Strom TM (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78:193–201PubMedCrossRef
30.
go back to reference Burnstein MI, Lawson JP, Kottamasu SR, Ellis BI, Micho J (1989) The enthesopathic changes of hypophosphatemic osteomalacia in adults: radiologic findings. AJR Am J Roentgenol 153:785–790PubMed Burnstein MI, Lawson JP, Kottamasu SR, Ellis BI, Micho J (1989) The enthesopathic changes of hypophosphatemic osteomalacia in adults: radiologic findings. AJR Am J Roentgenol 153:785–790PubMed
31.
go back to reference Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM (2009) Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int 85:235–246PubMedCrossRef Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM (2009) Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int 85:235–246PubMedCrossRef
32.
go back to reference Ros I, Alvarez L, Guanabens N, Peris P, Monegal A, Vázquez I, Cerdá D, Ballesta AM, Muñoz-Gómez J (2005) Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J Bone Miner Metab 23:266–269PubMedCrossRef Ros I, Alvarez L, Guanabens N, Peris P, Monegal A, Vázquez I, Cerdá D, Ballesta AM, Muñoz-Gómez J (2005) Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J Bone Miner Metab 23:266–269PubMedCrossRef
34.
go back to reference Chuck AJ, Pattrick MG, Hamilton E, Wilson R, Doherty M (1989) Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis 48:571–576PubMedCrossRef Chuck AJ, Pattrick MG, Hamilton E, Wilson R, Doherty M (1989) Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis 48:571–576PubMedCrossRef
35.
go back to reference Bhambri R, Naik V, Malhotra N, Taneja S, Rastogi S, Ravishanker U, Mithal A (2006) Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom 9:120–127PubMedCrossRef Bhambri R, Naik V, Malhotra N, Taneja S, Rastogi S, Ravishanker U, Mithal A (2006) Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom 9:120–127PubMedCrossRef
36.
go back to reference El-Desouki MI, Othman SM, Fouda MA (2004) Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J 25:355–358PubMed El-Desouki MI, Othman SM, Fouda MA (2004) Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J 25:355–358PubMed
Metadata
Title
Osteomalacia revisited
A report on 28 cases
Authors
Laia Gifre
Pilar Peris
Ana Monegal
Maria Jesús Martinez de Osaba
Luisa Alvarez
Núria Guañabens
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1587-z

Other articles of this Issue 5/2011

Clinical Rheumatology 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.